CRISPR used to uncover new drug targets for cancer
New potential drug targets have been identified for cancers associated with KRAS gene mutations, which are thought to drive around 20-30 percent of all human cancers...
A group of diseases that start when the signals that control how much and how often cells divide stop working properly. This causes cells to grow and multiply too much, and eventually to invade other tissues.
New potential drug targets have been identified for cancers associated with KRAS gene mutations, which are thought to drive around 20-30 percent of all human cancers...
A recent case is noteworthy not only for clinical negligence lawyers but also those interested in surrogacy and the wider public policy debate in the UK...
Organoids and CRISPR/Cas9 have been combined in a novel method to study genetic mutations occurring in cancer...
An existing drug has been shown to protect eggs from radiation and chemotherapy damage in research carried out in mice...
Two trials assessing gene therapy for blood cancer have been put on hold by the US Food and Drug Administration, following a patient fatality...
by Rikita Patel
The US Food and Drug Administration intends to investigate the use of unproven stem cell therapies being offered in the country's clinics...
The world's first cancer treatment which uses a patient's own genetically modified immune cells has been approved...
by Rachel Siden
A parliamentary inquiry in Australia is examining the impact of life insurance discrimination based on genetic test results...
US researchers have developed a new blood test to detect cancer-related DNA alterations before patients experience symptoms...
High doses of vitamin C may help fight certain leukaemias by boosting the activity of a particular gene, suggests a new study...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.